Cargando…

A mathematical model reveals the influence of NPIs and vaccination on SARS-CoV-2 Omicron Variant

An SVEIR SARS-CoV-2 Omicron variant model is proposed to provide some insights to coordinate non-pharmaceutical interventions (NPIs) and vaccination. Mathematically, we define the basic reproduction number [Formula: see text] and the effective reproduction number [Formula: see text] to measure the i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Bin-Guo, Wang, Zhi-Cheng, Wu, Yan, Xiong, Yongping, Zhang, Jiangqian, Ma, Zhuihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628561/ https://www.ncbi.nlm.nih.gov/pubmed/36339320 http://dx.doi.org/10.1007/s11071-022-07985-4

Ejemplares similares

Multiple testing and the effect of NPIs on the spread of SARS-CoV-2
por: Rothe, Christoph
Publicado: (2021)

Mathematical modelling of vaccination rollout and NPIs lifting on COVID-19 transmission with VOC: a case study in Toronto, Canada
por: Aruffo, Elena, et al.
Publicado: (2022)

EPH187 Effects of Non-Pharmaceutical Interventions (NPIS) Aimed at Limiting the Spread of SARS-COV-2
por: Pentz, R, et al.
Publicado: (2022)

Processing Attenuating NPIs in Indicative and Counterfactual Conditionals
por: Schwab, Juliane, et al.
Publicado: (2022)

Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants
por: Zhang, Yuntao, et al.
Publicado: (2022)

Assessing the impact of non-pharmaceutical interventions (NPIs) and BCG vaccine cross-protection in the transmission dynamics of SARS-CoV-2 in eastern Africa
por: Kilonzo, Chelsea Mbeke, et al.
Publicado: (2022)

Fractional order mathematical model for B.1.1.529 SARS-Cov-2 Omicron variant with quarantine and vaccination
por: Dickson, S., et al.
Publicado: (2023)

Mathematical modeling for Delta and Omicron variant of SARS-CoV-2 transmission dynamics in Greece
por: Liossi, Sofia, et al.
Publicado: (2023)

Changes in Pattern of Adherence to NPIs During the COVID-19 Pandemic
por: Clinton, Mobill, et al.
Publicado: (2021)

Compliance with NPIs and possible deleterious effects on mitigation of an epidemic outbreak
por: Barbarossa, Maria Vittoria, et al.
Publicado: (2021)

Editorial: The impact of non-pharmaceutical interventions (NPIs) on communicable diseases
por: Al Awaidy, Salah T., et al.
Publicado: (2023)

Vaccine Protection Against the SARS-CoV-2 Omicron Variant in Macaques
por: Chandrashekar, Abishek, et al.
Publicado: (2022)

Vaccine protection against the SARS-CoV-2 Omicron variant in macaques
por: Chandrashekar, Abishek, et al.
Publicado: (2022)

SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
por: Ao, Danyi, et al.
Publicado: (2022)

Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management
por: Chavda, Vivek P., et al.
Publicado: (2023)

Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants
por: Ong, Chon Phin, et al.
Publicado: (2023)

The mysterious origins of the Omicron variant of SARS-CoV-2
por: Du, Pei, et al.
Publicado: (2022)

Is the Omicron variant of SARS-CoV-2 coming to an end?
por: Zhao, Yingjie, et al.
Publicado: (2022)

Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna
por: Brault, Antoine, et al.
Publicado: (2022)

Why is the SARS-CoV-2 Omicron variant milder?
por: Xia, Bingqing, et al.
Publicado: (2022)

Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma
por: Wang, Yingdan, et al.
Publicado: (2022)

Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant
por: Zhang, Wei, et al.
Publicado: (2022)

Escape of SARS-CoV-2 Variant Omicron to Mucosal Immunity in Vaccinated Subjects
por: Martinuzzi, Emanuela, et al.
Publicado: (2022)

Vaccine Effect on Household Transmission of Omicron and Delta SARS-CoV-2 Variants
por: Kim, Yong Chan, et al.
Publicado: (2022)

Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies
por: Nadesalingam, Angalee, et al.
Publicado: (2023)

Plasma Neutralization of the SARS-CoV-2 Omicron Variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
por: Zhang, Na-Na, et al.
Publicado: (2022)

SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
por: Pather, Shanti, et al.
Publicado: (2023)

Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance
por: Rockett, Rebecca J., et al.
Publicado: (2022)

Disposable face masks and reusable face coverings as non-pharmaceutical interventions (NPIs) to prevent transmission of SARS-CoV-2 variants that cause coronavirus disease (COVID-19): Role of new sustainable NPI design innovations and predictive mathematical modelling
por: Rowan, Neil J., et al.
Publicado: (2021)

Challenges of SARS-CoV-2 Omicron Variant and appropriate countermeasures
por: Shao, Wenxia, et al.
Publicado: (2022)

The Diverse Landscape of Negative Polarity Items: On the Use of German NPIs as Experimental Diagnostics
por: Schaebbicke, Katharina, et al.
Publicado: (2021)

Treating SARS-CoV-2 Omicron variant infection by molnupiravir for pandemic mitigation and living with the virus: a mathematical modeling study
por: Zheng, Qinyue, et al.
Publicado: (2023)

Epidemiological Surveillance Reveals the Rise and Establishment of the Omicron SARS-CoV-2 Variant in Brazil
por: Silva, Joice do Prado, et al.
Publicado: (2023)

Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
por: Pather, Shanti, et al.
Publicado: (2023)

SARS-CoV-2 Omicron variant in cancer patients: an insight into the vaccine booster debate
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies
por: Schulz, Sebastian R., et al.
Publicado: (2022)

SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons
por: Rössler, Annika, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWH
por: Vergori, Alessandra, et al.
Publicado: (2022)

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
por: Suryawanshi, Rahul K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l10kd56ronkhn2abe21eb4m45a